Mindray Medical International (NYSE: MR) is one of 79 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it contrast to its peers? We will compare Mindray Medical International to related businesses based on the strength of its earnings, analyst recommendations, dividends, profitability, institutional ownership, valuation and risk.
Institutional and Insider Ownership
50.7% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 18.3% of shares of all “Advanced Medical Equipment & Technology” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This is a summary of current recommendations and price targets for Mindray Medical International and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Mindray Medical International||0||0||0||0||N/A|
|Mindray Medical International Competitors||271||1886||3385||108||2.59|
As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 10.67%. Given Mindray Medical International’s peers higher probable upside, analysts plainly believe Mindray Medical International has less favorable growth aspects than its peers.
This table compares Mindray Medical International and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Mindray Medical International||15.93%||12.70%||8.37%|
|Mindray Medical International Competitors||-150.16%||-23.71%||-9.03%|
Earnings and Valuation
This table compares Mindray Medical International and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Mindray Medical International||N/A||N/A||18.75|
|Mindray Medical International Competitors||$2.14 billion||$229.91 million||-30.03|
Mindray Medical International’s peers have higher revenue and earnings than Mindray Medical International. Mindray Medical International is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend. As a group, “Advanced Medical Equipment & Technology” companies pay a dividend yield of 0.9% and pay out 27.4% of their earnings in the form of a dividend. Mindray Medical International is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.
Mindray Medical International beats its peers on 5 of the 9 factors compared.
Mindray Medical International Company Profile
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Receive News & Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related companies with MarketBeat.com's FREE daily email newsletter.